OMER Omeros Corp

Price (delayed)

$3.15

Market cap

$182.52M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.88

Enterprise value

$537M

Omeros is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous ...

Highlights

Omeros's quick ratio has soared by 56% from the previous quarter and by 13% YoY

The debt has declined by 23% year-on-year and by 22% since the previous quarter

OMER's equity has dropped by 129% year-on-year and by 79% since the previous quarter

Sector: Healthcare

Industry: Biotechnology

Website: http://www.omeros.com

Peers: PFE JNJ DRRX

Key stats

What are the main financial stats of OMER

Market

Shares outstanding

57.94M

Market cap

$182.52M

Enterprise value

$537M

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

N/A

Price to sales (P/S)

N/A

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

N/A

Earnings

Revenue

EBIT

-$86.97M

EBITDA

-$86.05M

Free cash flow

$74.3M

Per share

EPS

-$1.88

Free cash flow per share

$1.18

Book value per share

-$0.4

Revenue per share

TBVPS

$6.03

Balance sheet

Total assets

$378.27M

Total liabilities

$403.25M

Debt

$361.58M

Equity

-$24.98M

Working capital

$164.58M

Liquidity

Debt to equity

-14.47

Current ratio

4.09

Quick ratio

3.38

Net debt/EBITDA

-4.12

Margins

EBITDA margin

N/A

Gross margin

N/A

Net margin

N/A

Operating margin

N/A

Efficiency

Return on assets

-24.1%

Return on equity

-1,290.7%

Return on invested capital

-10.9%

Return on capital employed

-26.8%

Return on sales

N/A

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

OMER stock price

How has the Omeros stock price performed over time

Intraday

2.94%

1 week

3.28%

1 month

-8.96%

1 year

-43.65%

YTD

-3.67%

QTD

-8.7%

Financial performance

How have Omeros's revenue and profit performed over time

Revenue

Gross profit

Operating income

-$164.53M

Net income

-$117.81M

Gross margin

N/A

Net margin

N/A

Growth

What is Omeros's growth rate over time

Valuation

What is Omeros stock price valuation

P/E

N/A

P/B

N/A

P/S

N/A

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

N/A

OMER's equity has dropped by 129% year-on-year and by 79% since the previous quarter

Efficiency

How efficient is Omeros business performance

The ROE has plunged by 112% YoY

Dividends

What is OMER's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for OMER.

Financial health

How did Omeros financials performed over time

The total assets is 6% less than the total liabilities

The current ratio has soared by 71% from the previous quarter and by 26% YoY

Omeros's quick ratio has soared by 56% from the previous quarter and by 13% YoY

OMER's equity has dropped by 129% year-on-year and by 79% since the previous quarter

Omeros's debt to equity has soared by 57% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.